Clin Gastroenterology H: The effect of HBeAg on the risk of hepatocellular carcinoma during oral antiviral treatment in patients with chronic hepatitis B
Clin Gastroenterology H: Normalization of fecal calprotectin levels within 12 months of diagnosis
Clin Gastroenterology H: What are the risk factors for colorectal stenosis in ulcerative colitis?
The eighth indication of K drug for advanced esophageal cancer was approved in China
Clin Cancer Res: Activity and safety of α-PD-L1 antibody ± α-TIM-3 antibody in the treatment of MSI-H/dMMR tumors
Lancet: Half of the world's cases are in China. Drug K brings good news for patients with esophageal cancer!
J Gastroenterology H: Eradication of Helicobacter pylori can prevent secondary gastric cancer in patients with mild to moderate atrophic gastritis
Clin Gastroenterology H: Fecal bacteria transplantation is safe and effective for patients with liver cirrhosis infected by Clostridium difficile
Is the K drug with 30 indications expected to conquer pancreatic cancer?
Heart: Non-vitamin K oral anticoagulant and glucocorticoid combined treatment of gastrointestinal bleeding risk in patients
Clin Gastroenterology H: The use of high-dose vitamin D does not prevent the recurrence of Crohn's disease after surgery
Nippon Capital acquires B&K, a German automotive coating manufacturer
There is growing evidence that vitamin K is good for heart health
Heart: The relationship between non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeding
A New Mechanism of the Polar Distribution of Sodium and Potassium ATPase During Nematode Sperm Activation
Professor Zhou Aiping: MSI-H/dMMR digestive system cancer treatment adds another weapon, the domestic PD-L1 nanoantibody Envolimab debuts
Nippon Paint wholly acquires German automotive coatings manufacturer B&K
Nordson launches new coating technology for plasticizing screws at K show
Merck's 2021H1 performance: revenue of 22 billion US dollars, K drug 8 billion US dollars, HPV vaccine growth 23%
J Gastroenterology H: Cell-free concentrated ascites reinfusion therapy (CART) has a good